Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11916523
[patent_doc_number] => 09784701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Phosphatidylalkanols and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 15/251764
[patent_app_country] => US
[patent_app_date] => 2016-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15598
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15251764
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/251764 | Phosphatidylalkanols and compositions thereof | Aug 29, 2016 | Issued |
Array
(
[id] => 11706169
[patent_doc_number] => 20170174669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES'
[patent_app_type] => utility
[patent_app_number] => 15/250742
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 36244
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15250742
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/250742 | POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES | Aug 28, 2016 | Abandoned |
Array
(
[id] => 13386189
[patent_doc_number] => 20180244636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => PROCESS FOR THE PREPARATION OF A DUAL-ACTING ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR COMPOUND
[patent_app_type] => utility
[patent_app_number] => 15/752943
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15752943
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/752943 | Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound | Aug 25, 2016 | Issued |
Array
(
[id] => 11887907
[patent_doc_number] => 09758457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions'
[patent_app_type] => utility
[patent_app_number] => 15/243980
[patent_app_country] => US
[patent_app_date] => 2016-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7259
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15243980
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/243980 | Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions | Aug 22, 2016 | Issued |
Array
(
[id] => 12188977
[patent_doc_number] => 20180047914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/556192
[patent_app_country] => US
[patent_app_date] => 2016-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19277
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556192 | Heterocyclic compound and organic light emitting element comprising same | Aug 22, 2016 | Issued |
Array
(
[id] => 12404826
[patent_doc_number] => 09968536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Composition comprising isosorbide monoesters and isosorbide diesters
[patent_app_type] => utility
[patent_app_number] => 15/240813
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4568
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15240813
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/240813 | Composition comprising isosorbide monoesters and isosorbide diesters | Aug 17, 2016 | Issued |
Array
(
[id] => 15726637
[patent_doc_number] => 10611739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Process for preparation of lactone derivatives and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 16/326239
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10745
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326239
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326239 | Process for preparation of lactone derivatives and intermediates thereof | Aug 15, 2016 | Issued |
Array
(
[id] => 13371841
[patent_doc_number] => 20180237461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => PHOSPHORIC ACID DIESTER SALT, PRODUCTION METHOD THEREFOR, NON-AQUEOUS ELECTROLYTIC SOLUTION FOR POWER STORAGE ELEMENT, AND POWER STORAGE ELEMENT
[patent_app_type] => utility
[patent_app_number] => 15/751841
[patent_app_country] => US
[patent_app_date] => 2016-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751841
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751841 | Phosphoric acid diester salt, production method therefor, non-aqueous electrolytic solution for power storage element, and power storage element | Aug 8, 2016 | Issued |
Array
(
[id] => 13636653
[patent_doc_number] => 09845283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Methods of producing cancer targeting compounds
[patent_app_type] => utility
[patent_app_number] => 15/232599
[patent_app_country] => US
[patent_app_date] => 2016-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 1
[patent_no_of_words] => 4902
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15232599
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/232599 | Methods of producing cancer targeting compounds | Aug 8, 2016 | Issued |
Array
(
[id] => 11311595
[patent_doc_number] => 20160347706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'Methods of Producing Cancer Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/232590
[patent_app_country] => US
[patent_app_date] => 2016-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5417
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15232590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/232590 | Methods of producing cancer treating compounds | Aug 8, 2016 | Issued |
Array
(
[id] => 11435970
[patent_doc_number] => 20170036991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'ISOLATION AND PURIFICATION OF 6-AMINOCAPROIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/228122
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3925
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15228122
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/228122 | Isolation and purification of 6-aminocaproic acid | Aug 3, 2016 | Issued |
Array
(
[id] => 13371695
[patent_doc_number] => 20180237388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYCOXYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 15/750887
[patent_app_country] => US
[patent_app_date] => 2016-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750887
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750887 | Process for the preparation of lactams from glyoxalic acid | Jul 31, 2016 | Issued |
Array
(
[id] => 13325865
[patent_doc_number] => 20180214470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => NEW EFFECTIVE AMINOGLYCOSIDE ANTIBIOTIC FOR MULTIDRUG-RESISTANT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/747581
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747581 | Effective aminoglycoside antibiotic for multidrug-resistant bacteria | Jul 28, 2016 | Issued |
Array
(
[id] => 13325865
[patent_doc_number] => 20180214470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => NEW EFFECTIVE AMINOGLYCOSIDE ANTIBIOTIC FOR MULTIDRUG-RESISTANT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/747581
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747581 | Effective aminoglycoside antibiotic for multidrug-resistant bacteria | Jul 28, 2016 | Issued |
Array
(
[id] => 13325865
[patent_doc_number] => 20180214470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => NEW EFFECTIVE AMINOGLYCOSIDE ANTIBIOTIC FOR MULTIDRUG-RESISTANT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/747581
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747581 | Effective aminoglycoside antibiotic for multidrug-resistant bacteria | Jul 28, 2016 | Issued |
Array
(
[id] => 13325865
[patent_doc_number] => 20180214470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => NEW EFFECTIVE AMINOGLYCOSIDE ANTIBIOTIC FOR MULTIDRUG-RESISTANT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/747581
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747581 | Effective aminoglycoside antibiotic for multidrug-resistant bacteria | Jul 28, 2016 | Issued |
Array
(
[id] => 11129242
[patent_doc_number] => 20160326216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'HCV PROTEASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/222592
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29175
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/222592 | HCV PROTEASE INHIBITORS AND USES THEREOF | Jul 27, 2016 | Abandoned |
Array
(
[id] => 15606135
[patent_doc_number] => 10584117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same
[patent_app_type] => utility
[patent_app_number] => 15/748081
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34038
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748081 | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same | Jul 26, 2016 | Issued |
Array
(
[id] => 13328369
[patent_doc_number] => 20180215722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => PROCESS FOR THE PREPARATION OF ISOCARBOXAZID
[patent_app_type] => utility
[patent_app_number] => 15/748209
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748209
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748209 | Process for the preparation of isocarboxazid | Jul 26, 2016 | Issued |
Array
(
[id] => 13300073
[patent_doc_number] => 20180201573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => NOVEL COMPOUND HAVING BLT INHIBITORY ACTIVITY AND COMPOSITION, FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 15/745337
[patent_app_country] => US
[patent_app_date] => 2016-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745337 | Compound having BLT inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient | Jul 22, 2016 | Issued |